BeStock  
Stocks › NRIX

Nurix Therapeutics NRIX

US equityMarket cap rank #2661Biotechnology
$22.88 −$0.11 (-0.48%)
Pre-market · Oct 6, 7:30 am ET · After hours $22.88 0.00%
Open$22.81
Prev close$22.99
Day range$22.43 – $23.31
Volume1.01M
Market cap$2.37B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.2%+0.29 pts vs. prior quarter
Institutions holding250+0 vs. prior quarter
Insider trades (recent)24 buys / 26 sellsNet selling
Short interest17.32% of floatDays to cover 14.1 · as of 15 Sep 2026
Short-sale volume share19.5%5-day average of daily volume

Short-sale volume as % of daily volume

11%17%22%28%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$12.95M (3 inflow days, 17 outflow days).

The five largest holders on file together own 36.0% of shares outstanding.

Largest holders

  • BlackRock8.45%
  • Vestal Point Capital, LP7.76%
  • Deep Track Capital, LP7.45%
  • Rubric Capital Management LP6.96%
  • Perceptive Advisors LLC5.33%
  • FMR5.28%
  • T. Rowe Price Group, Inc.5.24%
  • Vanguard Capital Management, LLC4.99%

By investor type

  • Mutual Fund53.95%
  • Hedge Fund34.56%
  • VC/PE Fund16.50%
  • Public Company7.14%
  • Private Company1.16%
  • Individual/Insider0.93%
  • Insurance Company0.43%
  • Government Pension Fund0.22%

Reported short interest has risen from 17.21% to 17.32% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 17,976,804 17.3% 14.1
31 Aug 2026 17,950,461 17.3% 15.9
14 Aug 2026 17,984,342 17.3% 18.1
31 Jul 2026 18,351,438 17.7% 18.0
15 Jul 2026 17,979,165 17.3% 13.9
30 Jun 2026 17,798,300 17.2% 5.4

Discussion

No comments yet — be the first to weigh in on NRIX.

Leave a comment

Scroll to Top